NCT04293783View on ClinicalTrials.gov

Randomized Double-blind Clinical Trial With L.Reuteri Supplementation in Children With Autism Spectrum Disorder

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

August 30, 2021

Conditions
Autism Spectrum Disorder
Interventions
DIETARY_SUPPLEMENT

L.Reuteri

daily supplementation with two tablet for six months

DIETARY_SUPPLEMENT

Placebo

daily supplementation with two tablet for six months

Trial Locations (2)

00100

University of Bari, Bari

00133

University of Rome Tor Vergata, Rome

All Listed Sponsors
collaborator

University of Bari

OTHER

lead

University of Rome Tor Vergata

OTHER

NCT04293783 - Randomized Double-blind Clinical Trial With L.Reuteri Supplementation in Children With Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter